Ian Lowes: A response to critics of structured products

‘For every argument, there is a counter-argument’

clock • 5 min read

Professional Adviser's recent article 'Structured products criticism stems from "utter ignorance" - Ian Lowes' has provoked some strong reactions - not least from the author of the quote himself …

I have always had an immense amount of respect for Hargreaves Lansdown (HL) and its senior management, writes Ian Lowes. In truth, who wouldn't? On the subject of structured products, however, we continue to be poles apart. I fundamentally disagree with Danny Cox's perspective, which featured in Professional Adviser's coverage of the publication of our 2016 Structured Product Annual Performance Review to the extent that, as a fellow Chartered Financial Planner with decades of experience of assessing all types of investments, including structured products, it baffles me. Let's accept t...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Advisers zoomed in on capital accumulation in Q4 2025

Advisers zoomed in on capital accumulation in Q4 2025

Titan Square Mile research finds

Jen Frost
clock 30 January 2026 • 3 min read
Measure for measure: How to track your tracker fund

Measure for measure: How to track your tracker fund

Tracking difference and tracking error

Terry McGivern
clock 28 January 2026 • 3 min read
SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

Healthcare, energy and EM preferred

Linus Uhlig
clock 28 January 2026 • 2 min read